The Blood-Based Biomarker for Sports Medicine Market was valued at USD 727.18 million in 2023 and is anticipated to reach USD 1347.68 million by 2032, expanding at a compound annual growth rate (CAGR) of 7.11% during the forecast period of 2024–2032. The global sports medicine industry is undergoing a transformation as diagnostic precision, personalized therapies, and preventive...